AFib Awareness: Advancing Treatment with Abbott's Volt PFA Technology
Description
September is Atrial Fibrillation Awareness Month. Patients living with Atrial Fibrillation, or AFib, are at greater risk for stoke, heart failure and dementia. Research suggests cases of AFib are likely to grow across the United States.
In this episode of the Medical Alley Podcast, host Ben Wagner talks with Dr. Christopher Piorkowski, chief medical officer of Abbott's electrophysiology business, about AFib's impact on millions of patients worldwide. They also discuss how Abbott's innovative Volt Pulsed Field Ablation (PFA) system is improving treatment by safely and precisely targeting heart tissue, helping reduce complications and improve patient outcomes.
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
United States
